Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism

J Thromb Haemost. 2008 Jan;6(1):203-5. doi: 10.1111/j.1538-7836.2007.02811.x. Epub 2007 Oct 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Humans
  • Janus Kinase 2 / genetics*
  • Mutation, Missense
  • Prevalence
  • Venous Thromboembolism / epidemiology
  • Venous Thromboembolism / genetics*

Substances

  • Janus Kinase 2